Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System.
This article is open to POST-PUBLICATION REVIEW. Registered readers (see "For Readers") may comment by clicking on ABSTRACT on the issue's contents page.
PMID: 26158287 [PubMed - in process]
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Uddin MN, Kouzi SA, Hussain MD Tags: J Pharm Pharm Sci Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Drugs & Pharmacology | Genital Warts | Head and Neck Cancer | Human Papillomavirus (HPV) | Merck | Nanotechnology | Oral Cancer | Skin | Vaccines | Warts